Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 9/20 | 0.48 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.46 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.40 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.40 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | HTR6 | P50406 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.37 |
| ▸ | ERN1 | O75460 | 1/20 | 0.37 |
| ▸ | PTPRC | P08575 | 1/20 | 0.37 |
| ▸ | LPL | P06858 | 1/20 | 0.37 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4244577 | 0.81 | DAO (0.44) | KDM4E | |
| SCHEMBL22734782 | 0.76 | CYP2A6 (0.48) | CYP2A6CYP2B6CYP2E1KCNH2PDGFRB | |
| SCHEMBL2125063 | 0.75 | CYP2A6 (0.72) | CYP2A6CYP2B6CYP2E1KCNH2PDGFRB | |
| SCHEMBL883778 | 0.73 | ALDH1A1 (0.44) | CYP2A6CYP2B6CYP2E1KDM4E | |
| SCHEMBL14198883 | 0.73 | ALDH1A1 (0.41) | KDM4E | |
| SCHEMBL5226951 | 0.71 | MAPT (0.50) | CYP3A4CYP2C9CYP2C19KDM4E | |
| SCHEMBL6192775 | 0.71 | ERN1 (0.50) | CYP2A6CYP2B6CYP2E1KCNH2CYP3A4 | |
| SCHEMBL29136542 | 0.71 | CYP2A6 (0.59) | CYP2A6CYP2B6CYP2E1KCNH2PDGFRB | |
| SCHEMBL27989815 | 0.70 | CYP2A6 (0.74) | CYP2A6CYP2B6CYP2E1KCNH2CYP3A4 | |
| SCHEMBL2782336 | 0.70 | CYP2A6 (0.58) | CYP2A6CYP2B6CYP2E1KCNH2PDGFRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11258020-B2 | Crosslinking p-dopants for p-doping organic hole conductors | OSRAM OLED GMBH (DE) | 2022-02-22 | — | — | US | disclosed |
| US-20190140190-A1 | CROSSLINKING P-DOPANTS FOR P-DOPING ORGANIC HOLE CONDUCTORS | MERCK PATENT GMBH (DE) | 2019-05-09 | — | — | US | disclosed |
| US-7884209-B2 | as redox-dopant and/or emitter in electronic, optoelectronic or electroluminescent structural elements; oxidation and moisture resistance | NOVALED AG (DE) | 2011-02-08 | — | — | US | disclosed |
| US-7884209-B2 | as redox-dopant and/or emitter in electronic, optoelectronic or electroluminescent structural elements; oxidation and moisture resistance | NOVALED AG (DE) | 2011-02-08 | — | — | US | disclosed |
| US-20100234608-A1 | Use of Bora-Tetraazapentalenes | NOVALED AG (DE) | 2010-09-16 | — | — | US | disclosed |
| US-20100234608-A1 | Use of Bora-Tetraazapentalenes | NOVALED AG (DE) | 2010-09-16 | — | — | US | disclosed |
| EP-1926738-B1 | SYNTHESIS OF CYCLOPENTADIENEDITHIOPHENE DERIVATIVES | BASELL POLYOLEFINE GMBH (DE) | 2009-12-09 | — | — | EP | disclosed |
| US-20090118522-A1 | Synthesis of Cyclopentadienedithiophene Derivatives | BASELL POLYOLEFINE GMBH (DE) | 2009-05-07 | — | — | US | disclosed |
| US-20090118522-A1 | Synthesis of Cyclopentadienedithiophene Derivatives | BASELL POLYOLEFINE GMBH (DE) | 2009-05-07 | — | — | US | disclosed |
| US-20090118522-A1 | Synthesis of Cyclopentadienedithiophene Derivatives | BASELL POLYOLEFINE GMBH (DE) | 2009-05-07 | — | — | US | disclosed |
| EP-1926738-A1 | SYNTHESIS OF CYCLOPENTADIENEDITHIOPHENE DERIVATIVES | Basell Polyolefine GmbH (DE) | 2008-06-04 | — | — | EP | disclosed |
| US-7332858-B2 | Light emitting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-02-19 | — | — | US | disclosed |
| US-7332858-B2 | Light emitting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-02-19 | — | — | US | disclosed |
| WO-2007110228-A1 | N-HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRONIC, OPTOELECTRONIC AND ELECTROLUMINESCENT COMPONENTS | NOVALED AG (DE) | 2007-10-04 | — | — | WO | disclosed |
| EP-1840120-A1 | N-Heterocyclic compounds and their use in electronic, optoelectronic and electroluminiscent components | Novaled AG (DE) | 2007-10-03 | — | — | EP | disclosed |
| WO-2007033937-A1 | SYNTHESIS OF CYCLOPENTADIENEDITHIOPHENE DERIVATIVES | BASELL POLYOLEFINE GMBH (DE) | 2007-03-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234608-A1 | Use of Bora-Tetraazapentalenes | ETFA, GPX1, CYBB | CYP2A6 1030/4885CYP2B6 973/4885CYP2E1 615/4885 |
| US-20090118522-A1 | Synthesis of Cyclopentadienedithiophene Derivatives | CCNT1, CBR1, TST | CYP2A6 357/4885CYP2B6 193/4885CYP2E1 65/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.